|

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting

RECRUITINGN/ASponsored by Baskent University
Actively Recruiting
PhaseN/A
SponsorBaskent University
Started2023-11-10
Est. completion2025-12-30
Eligibility
Age7 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06120764

Summary

The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.

Eligibility

Age: 7 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* 7 to 18 years old,
* who will receive intravenous chemotherapy,
* no cognitive or neurological disease that would prevent communication,
* receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
* no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency),
* children whose parents and themselves volunteered to participate in the study

Exclusion Criteria:

* Children receiving radiotherapy,
* taking ginger powder or vitamins to reduce nausea,
* children who did not want to participate in the study

Conditions3

CancerChemotherapy Induced Nausea and VomitingPediatric Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.